Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Int J Parasitol ; 35(13): 1453-7, 2005 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-16002073

RESUMO

Schistosoma mansoni is known to be refractory to praziquantel treatment in the pre-patent period of infection. Since Schistosoma haematobium has a much longer pre-patent period (10-12 weeks vs. 5-6 for the former species), we asked the question whether a correspondingly longer period of insusceptibility exists in urinary schistosomiasis. In hamsters treated at different times after infection, S. haematobium was partially refractory to praziquantel when treatment was given at week 5, but showed practically full sensitivity at 7-8 weeks and later times. Schistosoma haematobium worms obtained at different times after infection and exposed in vitro to praziquantel were refractory to low drug concentrations between 4 and 6 weeks, but were clearly affected at higher concentrations and at later time points. We conclude that S. haematobium does not have a praziquantel-insensitive window longer than in S. manson, in spite of its much longer maturation period. In addition, refractoriness of immature stages can be overcome at higher drug concentrations.


Assuntos
Anti-Helmínticos/farmacologia , Praziquantel/farmacologia , Schistosoma haematobium/efeitos dos fármacos , Esquistossomose Urinária/tratamento farmacológico , Animais , Anti-Helmínticos/administração & dosagem , Anti-Helmínticos/uso terapêutico , Cricetinae , Relação Dose-Resposta a Droga , Esquema de Medicação , Mesocricetus , Praziquantel/administração & dosagem , Praziquantel/uso terapêutico , Schistosoma haematobium/crescimento & desenvolvimento , Esquistossomose Urinária/parasitologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA